These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8259545)

  • 1. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
    Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
    Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble fibrin species in arterial thrombi.
    Sandbaek G; Bjørnsen S; Sobel JH; Nieuwenhuizen W; Matsueda G; Brosstad F
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):1-5. PubMed ID: 10691094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease.
    Shainoff JR; Valenzuela R; Urbanic DA; DiBello PM; Lucas FV; Graor R
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):499-503. PubMed ID: 1983461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen.
    Siebenlist KR; Mosesson MW
    Biochemistry; 1996 May; 35(18):5817-21. PubMed ID: 8639542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
    Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
    Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early alpha chain crosslinking in human fibrin preparations.
    Sobel JH; Thibodeau CA; Canfield RE
    Thromb Haemost; 1988 Oct; 60(2):153-9. PubMed ID: 3217916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ; Minkema J; Bouma BN; Jansen JW
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
    Gerner C; Steinkellner W; Holzmann K; Gsur A; Grimm R; Ensinger C; Obrist P; Sauermann G
    Thromb Haemost; 2001 Mar; 85(3):494-501. PubMed ID: 11307821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
    Matsuka YV; Medved LV; Migliorini MM; Ingham KC
    Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cross-linked fibrin in human plasma contains alpha-polymers with intact fibrinopeptide A.
    Grøn B; Filion-Myklebust C; Bennick A; Nieuwenhuizen W; Matsueda GR; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):731-6. PubMed ID: 1489895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemical properties of plasma fibrinogens and fibrins from normal and cobalt-treated rabbits].
    Lober M; Krantz S
    Acta Biol Med Ger; 1975; 34?710():1573-88. PubMed ID: 1233845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.
    Shainoff JR; Dardik BN
    J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.